The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids

Author(s): de la Monte SM, Longato L, Tong M, DeNucci S, Wands JR

Abstract

Alcohol abuse causes progressive toxicity and degeneration in liver and brain due to insulin resistance, which exacerbates oxidative stress and pro-inflammatory cytokine activation. Alcohol-induced steatohepatitis promotes synthesis and accumulation of ceramides and other toxic lipids that cause insulin resistance. Ceramides can readily cross the blood-brain barrier, and ceramide exposure causes neurodegeneration with insulin resistance and oxidative stress, similar to the effects of alcohol. Therefore, in addition to its direct neurotoxic effects, alcohol misuse establishes a liver-brain axis of neurodegeneration mediated by toxic lipid trafficking across the blood-brain barrier, leading to progressive white matter degeneration and cognitive impairment.

Similar Articles

Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines

Author(s): Miller AM, Horiguchi N, Jeong WI, Radaeva S, Gao B

Alcoholic liver disease-related mortality in the United States: 1980-2003

Author(s): Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, et al.

Molecular mechanisms of alcoholic fatty liver

Author(s): Purohit V, Gao B, Song BJ

Insulin resistance in experimental alcohol-induced liver disease

Author(s): de la Monte SM, Yeon JE, Tong M, Longato L, Chaudhry R, et al.

Acute ethanol exposure inhibits insulin signaling in the liver

Author(s): He J, de la Monte S, Wands JR

Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation

Author(s): Onishi Y, Honda M, Ogihara T, Sakoda H, Anai M, et al.

Alcohol-induced disruption of endocrine signaling

Author(s): Ronis MJ, Wands JR, Badger TM, de la Monte SM, Lang CH, et al.

Acetaldehyde adducts in alcoholic liver disease

Author(s): Setshedi M, Wands JR, Monte SM

Pioglitazone: side effect and safety profile

Author(s): Shah P, Mudaliar S

Roles of PPARs in NAFLD: Potential therapeutic targets

Author(s): Tailleux A, Wouters K, Staels B

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

Author(s): Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, et al.

Peroxisome proliferator-activated receptor agonist treatment of alcohol-induced hepatic insulin resistance

Author(s): de la Monte SM, Pang M, Chaudhry R, Duan K, Longato L, et al.

Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met

Author(s): Tomita K, Azuma T, Kitamura N, Nishida J, Tamiya G, et al.

Alcohol abuse, endoplasmic reticulum stress and pancreatitis

Author(s): Pandol SJ, Gorelick FS, Gerloff A, Lugea A

Binge ethanol exposure increases liver injury in obese rats

Author(s): Carmiel-Haggai M, Cederbaum AI, Nieto N

Alcoholic foamy degeneration--a pattern of acute alcoholic injury of the liver

Author(s): Uchida T, Kao H, Quispe-Sjogren M, Peters RL

Induction of megamitochondria in the rat liver by N-propyl alcohol and N-butyl alcohol

Author(s): Wakabayashi T, Horiuchi M, Sakaguchi M, Onda H, Iijima M

Effects of N-acetylcysteine on ethanol-induced hepatotoxicity in rats fed via total enteral nutrition

Author(s): Ronis MJ, Butura A, Sampey BP, Shankar K, Prior RL, et al.